Member | HIV-1 Subtype | Isolate | Country of Origin | Syncytium | Co-receptor Usage | Percent inhibition of p24 production |
---|---|---|---|---|---|---|
PRD320-01 | A | UG275 | Uganda | NSI | CCR5 | 88.3% |
PRD320-02 | A | I-2496 | Ghana | NSI | CCR5 | 99.8% |
PRD320-03 | CRF02_AG | DJ263 | Djibouti | NSI | CCR5 | 94.7% |
PRD320-04 | CRF02_AG | POC44951 | Liberia | NSI | CCR5 | 99.7% |
PRD320-06 | B | BZ167 | Brazil | SI | CXCR4 | 97.2% |
PRD3200-7 | C | DJ259 | Djibouti | NSI | CCR5 | 91.5% |
PRD320-08 | C | ZAM18 | Zambia | NSI | CCR5 | 93.7% |
PRD320-09 | D | SE365 | Senegal | SI | CXCR4 | 98.5% |
PRD320-10 | D | UG270 | Uganda | SI | CXCR4 | 99.7% |
PRD320-11 | CRF01_AE | ID17 | Indonesia | NSI | CCR5 | 81.0% |
PRD320-12 | CRF01_AE | NP03 | Thailand | SI | CXCR4 | 94.5% |
PRD320-14 | F | BCI-R07 | Romania | SI | CXCR4/CCR5 | 99.4% |
PRD320-15 | G | BCF-DIOUM | Zaire | NSI | CCR5 | 99.9% |
PRD320-16 | G | HH8793 | Kenya | NSI | CCR5 | 83.3% |
PRD320-17 | H | BCF-KITA | Zaire | NSI | CCR5 | 92.5% |
PRD320-18 | O | BCF06 | Cameroon | SI | CXCR4/CCR5 | 98.3% |
PRD320-19 | O | I-2478B | US | NSI | CCR5 | 65.6% |